Sun Pharma to acquire Organon in $11.75 bln all-cash deal
Sun Pharmaceutical Industries will acquire Organon & Co in an all‑cash deal, valuing the U.S. drugmaker at about $11.75 billion, the companies said in a joint statement on Sunday.
More info
